Investmark Advisory Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $328K | Hold |
2,590
| – | – | 0.15% | 97 |
|
|
2025
Q1 | $331K | Buy |
2,590
+2
| +0.1% | +$256 | 0.16% | 89 |
|
|
2024
Q4 | $342K | Buy |
2,588
+1
| +0% | +$132 | 0.17% | 87 |
|
|
2024
Q3 | $377K | Buy |
2,587
+4
| +0.2% | +$582 | 0.18% | 85 |
|
|
2024
Q2 | $355K | Sell |
2,583
-1
| -0% | -$137 | 0.19% | 82 |
|
|
2024
Q1 | $355K | Buy |
2,584
+3
| +0.1% | +$412 | 0.19% | 84 |
|
|
2023
Q4 | $351K | Buy |
2,581
+4
| +0.2% | +$544 | 0.21% | 84 |
|
|
2023
Q3 | $315K | Hold |
2,577
| – | – | 0.21% | 80 |
|
|
2023
Q2 | $327K | Buy |
2,577
+1
| +0% | +$127 | 0.22% | 79 |
|
|
2023
Q1 | $333K | Buy |
2,576
+1
| +0% | +$129 | 0.24% | 71 |
|
|
2022
Q4 | $338K | Buy |
2,575
+2
| +0.1% | +$263 | 0.25% | 75 |
|
|
2022
Q3 | $300K | Buy |
2,573
+3
| +0.1% | +$350 | 0.27% | 66 |
|
|
2022
Q2 | $302K | Buy |
2,570
+1
| +0% | +$118 | 0.3% | 53 |
|
|
2022
Q1 | $334K | Buy |
2,569
+2
| +0.1% | +$260 | 0.34% | 56 |
|
|
2021
Q4 | $391K | Buy |
+2,567
| New | +$391K | 0.37% | 47 |
|